Published in Br J Cancer on August 06, 2013
Complexity and stability in growing cancer cell populations. Proc Natl Acad Sci U S A (2015) 1.06
The mathematics of cancer: integrating quantitative models. Nat Rev Cancer (2015) 1.00
Endothelin-1/endothelin A receptor-mediated biased signaling is a new player in modulating human ovarian cancer cell tumorigenesis. Cell Signal (2014) 0.91
Dynamics of growth factor production in monolayers of cancer cells and evolution of resistance to anticancer therapies. Evol Appl (2013) 0.83
Evolutionarily stable anti-cancer therapies by autologous cell defection. Evol Med Public Health (2013) 0.81
Edge effects in game-theoretic dynamics of spatially structured tumours. J R Soc Interface (2015) 0.79
Heterogeneity and proliferation of invasive cancer subclones in game theory models of the Warburg effect. Cell Prolif (2015) 0.77
Evolutionary Dynamics of Tumor-Stroma Interactions in Multiple Myeloma. PLoS One (2016) 0.76
Cancer treatment scheduling and dynamic heterogeneity in social dilemmas of tumour acidity and vasculature. Br J Cancer (2017) 0.75
Evolutionary emergence of angiogenesis in avascular tumors using a spatial public goods game. PLoS One (2017) 0.75
Evolutionary stability in continuous nonlinear public goods games. J Math Biol (2016) 0.75
The hallmarks of cancer. Cell (2000) 113.05
The clonal evolution of tumor cell populations. Science (1976) 24.39
Clonal evolution in cancer. Nature (2012) 11.07
Mutation selection and the natural history of cancer. Nature (1975) 9.73
Cancer as an evolutionary and ecological process. Nat Rev Cancer (2006) 9.33
Genetic clonal diversity predicts progression to esophageal adenocarcinoma. Nat Genet (2006) 6.71
Tumor heterogeneity: causes and consequences. Biochim Biophys Acta (2009) 5.90
Biochemistry by numbers: simulation of biochemical pathways with Gepasi 3. Trends Biochem Sci (1997) 5.64
A microenvironmental model of carcinogenesis. Nat Rev Cancer (2008) 4.40
Evolutionary dynamics of group interactions on structured populations: a review. J R Soc Interface (2013) 4.14
Evolution of cooperation among tumor cells. Proc Natl Acad Sci U S A (2006) 2.63
Metapopulation dynamics and spatial heterogeneity in cancer. Proc Natl Acad Sci U S A (2002) 2.17
Heterogeneity of angiogenic activity in a human liposarcoma: a proposed mechanism for "no take" of human tumors in mice. J Natl Cancer Inst (2001) 2.10
Review: Game theory of public goods in one-shot social dilemmas without assortment. J Theor Biol (2011) 2.02
Mathematical oncology: cancer summed up. Nature (2003) 1.67
An analogy between the evolution of drug resistance in bacterial communities and malignant tissues. Nat Rev Cancer (2011) 1.58
Evolutionary biology of cancer. Trends Ecol Evol (2005) 1.58
Coexistence of cooperation and defection in public goods games. Evolution (2010) 1.53
Tumor heterogeneity and drug resistance. J Clin Oncol (1986) 1.47
Cancer phenotype as the outcome of an evolutionary game between normal and malignant cells. Br J Cancer (2009) 1.35
Game-theory models of interactions between tumour cells. Eur J Cancer (1997) 1.35
Evolutionary foundations for cancer biology. Evol Appl (2013) 1.25
Modeling cell signaling networks. Biol Cell (2004) 1.21
The impact of Bevacizumab (Avastin) on survival in metastatic solid tumors--a meta-analysis and systematic review. PLoS One (2013) 1.20
Modelling the consequences of interactions between tumour cells. Br J Cancer (1997) 1.20
Evolutionary game theory elucidates the role of glycolysis in glioma progression and invasion. Cell Prolif (2008) 1.14
Evolutionary dynamics of intratumor heterogeneity. PLoS One (2011) 1.14
Competition and natural selection in a mathematical model of cancer. Bull Math Biol (2004) 1.12
The role of IDH1 mutated tumour cells in secondary glioblastomas: an evolutionary game theoretical view. Phys Biol (2011) 1.09
The volunteer's dilemma and the optimal size of a social group. J Theor Biol (2009) 1.09
A minority of carcinoma cells producing acidic fibroblast growth factor induces a community effect for tumor progression. Proc Natl Acad Sci U S A (1994) 1.08
Drugs that target pathogen public goods are robust against evolved drug resistance. Evol Appl (2012) 0.98
Investigating prostate cancer tumour-stroma interactions: clinical and biological insights from an evolutionary game. Br J Cancer (2011) 0.88
H. The kinetics of enzyme cascade systems. General kinetics of enzyme cascades. Proc R Soc Lond B Biol Sci (1969) 0.80
Survival of the steepest: hypersensitivity to mutations as an adaptation to soft selection. J Evol Biol (2009) 0.80
Catalytic efficiency, kinetic co-operativity of oligomeric enzymes and evolution. J Theor Biol (1986) 0.80